Pulmonary & Respiratory Medicine

Severe Asthma Therapies

Severe asthma represents a challenging and complex form of respiratory disease that requires advanced therapeutic approaches and personalized management strategies. This session will examine the latest developments in the treatment and management of severe and difficult-to-control asthma. Researchers and clinicians will discuss emerging therapies designed to target the underlying inflammatory pathways responsible for severe asthma symptoms. Recent advancements in biologic therapies have significantly improved treatment outcomes for patients who do not respond adequately to conventional inhaled medications. These targeted treatments work by addressing specific immune pathways involved in airway inflammation, allowing for more effective disease control and reduced exacerbations. Participants will gain insights into the mechanisms of action, clinical applications, and patient selection criteria for these innovative therapies. The session will also explore new diagnostic tools and biomarkers that help identify asthma phenotypes and guide treatment decisions. Personalized treatment approaches, combined with patient monitoring technologies, are enabling healthcare professionals to optimize therapy and improve long-term disease management. Additionally, discussions will cover the importance of multidisciplinary care, patient education, and adherence to treatment plans. By integrating advanced therapies with comprehensive care strategies, the management of severe asthma continues to evolve, offering new hope for improved patient outcomes and enhanced quality of life.